TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: 1-Year Overall Survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of weakly acidic reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum Serum Concentration (C[max])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-Time Curve From Time Zero to Infinite Time (AUC [infinity])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-Time Curve From Time Zero to Infinite Time (AUC [last])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of upstaging from Lobular Neoplasia to invasive breast cancer or ductal carcinoma in situ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Interference with cardiac implantable electronic devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subject overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Grade 2 adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of pancreatic fistula grade B/C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Presence of Detrusor Muscle on histopathological analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient well-being measured by OBAS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient well-being measured by BPI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Biochemical indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVs values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of severe vs moderate influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Recurrence of Thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants Needing Intervention to Treat Blood Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sequential organ failure assessment (SOFA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy Rate of Root Canal Obturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of direct oral anti-coagulants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Conversion of PSVT to Sinus Rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of Paramedics' assessments of ultrasound for B-lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematopoietic Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Child's facial expressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tear protein profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in opioid prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Long-term opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: Time needed to block cavo-tricuspidal isthmus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants Who Had Prostate Specific Antigen (PSA) Discussion With Physician at 3 Months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Had PSA Testing at 3 Months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Had PSA Testing at 3 Years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Palpable induration inside the boost volume of the irradiated breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Radiographic progression free survival (rPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Overweight and obesity prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overweight and obesity incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinically important medication errors
Endpoint domain: Adverse events/effects
Primary endpoint: Diffusion tensor imaging of corticospinal tracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: improvement of bladder function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Subjects Completing Therapy Including Surgical Resection
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clearing CMV viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MACCE Events at 30 days or discharge
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from Hemodynamic compromise during PCI procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absence of fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tolerability (Dose-limiting Toxicity)
Endpoint domain: Adverse events/effects
Primary endpoint: Protein concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Striatal [^123I]-Iodobenzamine (IBZM) Binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cumulative excretion of radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in spoken naming of target items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in script production accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of treatment with SVF IV
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of sensory blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic effect on labor pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Perception on Monosyllabic Word Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Disability Inventory
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intradialytic symptomatic hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shade matching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feedback on general experience
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feedback on clinical performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in the Microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unbound bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement of clinical picture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Bother Scale Result
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bioequivalence Based on AUCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence Based on AUC∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in thickness of the plantar fascia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in echointensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Echovariation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clotting-fibrinolysis patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet function markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Insulin kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in HAI titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cognitive performance measured by Digit-Symbol Substitution Task (DSST)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Risk assessment measured by Balloon Analog Risk Test (BART)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention and reaction time measured by Psychomotor Vigilance Test (PVT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI BOLD Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative interleukins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in Body Mass Index (BMI) child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Fat Mass Index (FMI) child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in 24 hours drinking volume of milk intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DEXA scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting blood sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum-tolerated dose (MTD) of duvelisib
Endpoint domain: Adverse events/effects
Primary endpoint: Cholesteryl Ester Fractional Clearance Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Low Density Lipoprotein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in internalizing and externalizing problems per self- and caregiver-report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in internalizing and externalizing problems per teacher-report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in school engagement per self- and caregiver-report
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in school engagement per teacher-report
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Academic outcomes, assessed via school grades and standardized test performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of procedure-related common expected procedure outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Experiencing a Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Subjective Patient Change in Irritative Urinary Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Metabolic profiles of CSF and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Standardized Uptake Value (SUV)/Standardized Uptake Value Ratio (SUVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Beck Depression Index BDI-II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of migraine attack
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure Pain Threshold Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Severity Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in sleep duration and sleep quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in activity levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of days with visits at the fitness center chain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of membership terminations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Percent Correct Word Recognition Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sleep characteristics
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: size of corpus callosum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PHQ-9 score change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants with a successful outcome at the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with a successful outcome at the end of follow up at 76 weeks post treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who experience grade 3 or greater adverse events during treatment and up to 30 days following the end of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve of paracetamol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve of post prandial plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Etiologic categorization of nonedematous hyponatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of moderate molecule substance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of immunological positive answer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Post thoracotomy pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of endometrial hyperplasia without atypia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inappropriate transfer to ED
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Immunogenicity of TBE vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose for Cyclophosphamide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: En Bloc resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from Baseline GERD-HRQL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in hepatic triglyceride content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the concentration-time curve from time 0 to infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time 0 to Day 85 (AUC84d)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bristol Stool Scores (consistency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean number of bowel movements (frequency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean Change in Best Corrected Visual Acuity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seroprotection rate of diphtheria and tetanus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 related hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: 1 year graft occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 30 days PCS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 30 days MCS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Myopic progression >0.75 D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in Best Corrected Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composition in gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood lipid including cholesterol, triglycerides, high-density lipoprotein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum tolerated dose (MTD) of SM08502 based on the frequency and severity of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment-emergent adverse events (TEAEs) as assessed by CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor response as measured by RECIST 1.1 or PCWG3 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: response evaluation after the fourth therapy course
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: response rate to the 60-days oral chemotherapy with temozolomide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: response rate to the 5-week intraventricular therapy with etoposide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy of local tumor ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: optic nerve sheath diameter change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical Success of the Study Devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Vaccination Rate, All Ages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Vaccination Rate, Employees 18 to 49 Years of Age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom From VBX Stent Graft-related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of imprinting cancer early detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity of imprinting cancer early detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mean change in cuff seated trough diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean change in cuff seated systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean change in automated blood pressure monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Curve (AUC0-24h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sunscreen Application Behavior Changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sunscreen Re-Application Behavior Changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Tanning Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: composite clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure offset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg Rest Pain Score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Pain During Debridement Score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Safety information based on all serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety information based on related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Safety information based on related non-serious adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Dose Limiting Toxicities of Palbociclib
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Adverse Events of Palbociclib
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Drug Concentration Curve of Palbociclib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence of ventricular arrythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evidence of myocardial fibrosis on cardiac MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Pediatric Participants With Problems Understanding Item Wording-Round 1 Interviews
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Pediatric Participants With Difficulty Providing Responses to Items-Round 1 Interviews
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning